Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

CEREMEXIN™ solution for IV and IM injection 250mg/ml (4ml), ampoules 5pcs

🔥 3 items sold in last 3 hours
12 people are viewing this product
Brand:
Active Ingredient:

Manufacturer:

$27.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

CEREMEXIN™ solution for IV and IM injection 125mg/ml (4ml), ampoules 5pcs

$20.00
Add to cart

Analogs of CEREMEXIN™

NEYPILEPT™ solution for IV/IM injection 250mg/ml (4ml), 5pcs

$27.00
Add to cart

NEYPILEPT™ solution for IV/IM injection 125mg/ml (4ml), 5pcs

$17.00
Add to cart

NEYPILEPT™ oral solution 100mg/ml (100ml), 1pc

$98.00
Add to cart

NEYPILEPT™ oral solution 100mg/ml (300ml), 1pc

$210.00
Add to cart

Table of Contents

CEREMEXIN™ 250mg/ml Solution 4ml Buy Online

CEREMEXIN Solution for IV and IM Injection: A Comprehensive Overview

What is CEREMEXIN?

CEREMEXIN is a medication used to treat various neurological conditions. Its active ingredient, citicoline, plays a crucial role in cell membrane repair and protection. This makes it effective in addressing conditions stemming from brain injury or dysfunction.

Citicoline, the key component of CEREMEXIN, acts as a precursor to essential components of cell membranes, primarily phospholipids. By boosting phospholipid synthesis, it aids in repairing damaged cell membranes and protecting against further damage. This protective effect helps improve cognitive function and neurological recovery.

CEREMEXIN is primarily employed in the treatment of neurological disorders. It’s shown efficacy in improving symptoms associated with cerebrovascular events, such as stroke, and in managing the effects of neurodegenerative diseases. The medication helps to alleviate symptoms, supporting recovery and improved quality of life.

The appropriate dosage of CEREMEXIN is determined by the physician based on individual patient needs and the specific condition being treated. It is typically administered intravenously or intramuscularly, as indicated by a healthcare professional. Precise instructions must be followed carefully.

While generally well-tolerated, CEREMEXIN can cause some side effects, although these are usually mild. Some reported side effects include nausea, diarrhea, and headaches. Serious adverse reactions are rare but necessitate immediate medical attention.

  • Effective in treating various neurological conditions.
  • Aids in cell membrane repair and protection.
  • Improves cognitive function and neurological recovery.
  • Generally well-tolerated with mild side effects.
  • Potential for mild side effects such as nausea and headaches.
  • Requires intravenous or intramuscular administration.
  • Dosage must be determined and monitored by a healthcare professional.

CEREMEXIN should be used with caution in pregnant or breastfeeding women. Individuals with specific allergies or pre-existing medical conditions should discuss its use with their doctor. Always adhere to prescribed dosage and administration guidelines.

Conclusion

CEREMEXIN provides a valuable therapeutic option for various neurological disorders. Its mechanism of action, focusing on cell membrane repair and protection, contributes to its efficacy in improving cognitive function and neurological recovery. As with all medications, proper consultation with a healthcare professional is crucial to ensure safe and effective use.

What is CEREMEXIN?

CEREMEXIN, a parenteral solution for intravenous (IV) and intramuscular (IM) administration, is a crucial medication in the treatment of various neurological conditions. Its primary active ingredient, citicoline, is a naturally occurring compound that plays a vital role in brain cell function and repair. This unique formulation is designed for direct delivery into the bloodstream, ensuring rapid absorption and efficient distribution throughout the central nervous system.

The mechanism of action centers on citicoline’s ability to enhance the synthesis of phospholipids, essential structural components of cell membranes, particularly within brain cells. This process is critical for maintaining the structural integrity and functionality of neurons, protecting them from damage caused by various factors, including ischemia (reduced blood flow) and trauma. By bolstering cell membrane integrity, CEREMEXIN helps to prevent further cell death and supports the recovery of damaged neural tissue.

Specifically, citicoline’s influence extends to several key cellular processes. It modulates the activity of phospholipases, enzymes that can break down cell membranes, thereby reducing the potential for further damage. Furthermore, it contributes to the production of neurotransmitters, chemical messengers crucial for communication between brain cells. This multifaceted approach makes CEREMEXIN an effective treatment for a range of neurological disorders, improving cognitive function and overall neurological health.

Importantly, CEREMEXIN’s effectiveness isn’t limited to acute conditions; it also demonstrates potential benefits in chronic neurodegenerative diseases. This broader application highlights its versatility and potential as a long-term therapeutic option for individuals suffering from a range of neurological impairments. Further research continually expands our understanding of citicoline’s diverse therapeutic potential within the context of brain health and repair.

Mechanism of Action

CEREMEXIN’s therapeutic effects stem from its active ingredient, citicoline, a crucial compound in cellular processes related to brain function and repair. Citicoline acts as a precursor to phosphatidylcholine, a major component of neuronal cell membranes. By increasing phosphatidylcholine synthesis, CEREMEXIN helps to repair and maintain the integrity of these crucial cell membranes, protecting neurons from damage.

This membrane-stabilizing action is vital for neuronal function. Damaged cell membranes compromise the cell’s ability to regulate ion transport and maintain its electrochemical gradient, which is essential for nerve impulse transmission. CEREMEXIN’s ability to support cell membrane repair thus directly improves neuronal signaling and overall brain function. The restoration of membrane integrity also reduces the likelihood of further cellular damage.

Beyond membrane repair, citicoline influences neurotransmitter synthesis. It enhances the production of acetylcholine, a key neurotransmitter involved in cognitive processes like memory and learning. Increased acetylcholine levels contribute to improved cognitive function and potentially slow down cognitive decline associated with various neurological conditions. This dual mechanism of action—membrane stabilization and neurotransmitter enhancement—underlies CEREMEXIN’s effectiveness.

Furthermore, citicoline exhibits antioxidant properties, helping to combat oxidative stress, a major contributor to neuronal damage in many neurological disorders. Oxidative stress results from an imbalance between free radical production and antioxidant defenses, leading to cellular damage. By mitigating oxidative stress, CEREMEXIN provides additional neuroprotection and further supports the recovery process. This multifaceted approach makes CEREMEXIN a powerful tool in the treatment of neurological conditions.

Therapeutic Uses

CEREMEXIN’s primary therapeutic application lies in the treatment of acute and chronic neurological conditions resulting from cerebrovascular events, such as ischemic stroke. Following a stroke, the brain experiences oxygen deprivation, leading to neuronal damage. CEREMEXIN’s ability to protect and repair neuronal cell membranes makes it a valuable tool in mitigating the long-term consequences of stroke, improving functional recovery and reducing disability.

Beyond stroke, CEREMEXIN’s therapeutic benefits extend to other neurological conditions marked by cognitive decline. In patients with dementia, particularly vascular dementia, CEREMEXIN has shown promise in improving cognitive functions, including memory and attention. This improvement in cognitive performance enhances the patient’s overall quality of life and functional independence, enabling them to participate more fully in daily activities.

Furthermore, research suggests a potential role for CEREMEXIN in traumatic brain injury (TBI). TBI can cause widespread neuronal damage, leading to various cognitive and motor impairments. CEREMEXIN’s neuroprotective and restorative properties may aid in reducing the severity of these impairments, promoting faster and more complete recovery. The ability to enhance cognitive function and motor skills following TBI is significant for patient rehabilitation.

The versatility of CEREMEXIN is also demonstrated in its potential use in the management of other neurological conditions. Studies have explored its use in various forms of cognitive impairment and other neurological disorders. This ongoing research continues to expand the understanding of CEREMEXIN’s therapeutic potential and its ability to positively impact the lives of those affected by neurological disease. The promising results in these diverse areas highlight the significant therapeutic potential of CEREMEXIN.

Dosage and Administration

CEREMEXIN is administered parenterally, meaning it’s injected directly into the body, bypassing the digestive system. The two primary routes of administration are intravenous (IV) injection, directly into a vein, and intramuscular (IM) injection, into a muscle. The choice of route depends on the patient’s condition and the physician’s assessment. Both methods ensure rapid absorption and distribution of citicoline throughout the body.

Dosage regimens for CEREMEXIN are highly individualized and determined by a healthcare professional based on several factors. These factors include the patient’s specific condition, overall health, and response to treatment. The physician carefully considers these variables to create a personalized treatment plan that maximizes therapeutic benefit while minimizing potential risks. Close monitoring of the patient’s response is vital during treatment.

Typical dosages often involve a specific amount of CEREMEXIN administered over a defined period, whether it be daily, weekly, or as directed by the healthcare provider. The duration of treatment varies greatly depending on the severity and nature of the neurological condition being addressed. Some treatment plans may involve a course of injections followed by a period of observation, while others may require ongoing administration for extended periods.

It is crucial to emphasize that CEREMEXIN should only be administered under the strict supervision of a qualified healthcare professional. Improper administration can lead to adverse effects, highlighting the importance of adhering to prescribed guidelines. Patients should always discuss any concerns or questions regarding their treatment regimen with their physician or other healthcare provider. This ensures the safe and effective use of the medication.

Potential Side Effects

While generally well-tolerated, CEREMEXIN, like all medications, can potentially cause adverse reactions. The majority of reported side effects are mild and transient, resolving spontaneously without intervention. However, patients should be aware of the potential for these side effects and report any concerning symptoms to their healthcare provider immediately.

Commonly reported side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. These are usually mild and can often be managed with supportive measures, such as adjusting medication timing relative to meals. In rare instances, more severe gastrointestinal reactions may occur, necessitating medical attention. Patients experiencing persistent or severe gastrointestinal distress should seek immediate medical advice.

Other potential side effects, though less frequent, include headaches, dizziness, and insomnia. These neurological side effects are generally mild and self-limiting, meaning they resolve on their own without treatment. However, if these symptoms are severe or persistent, it is crucial to inform the prescribing physician. They may adjust the dosage or recommend alternative management strategies.

Serious adverse reactions are rare with CEREMEXIN. However, patients should be vigilant and report any unusual or concerning symptoms to their healthcare provider immediately. These could include severe allergic reactions (anaphylaxis), characterized by symptoms such as difficulty breathing, swelling of the face or throat, and hives. Prompt medical attention is crucial in such cases to prevent life-threatening complications. Close monitoring during treatment is essential to promptly identify and manage any potential adverse events.

Pros

CEREMEXIN offers several significant advantages in the treatment of neurological conditions. Its primary benefit lies in its efficacy in improving cognitive function and promoting neurological recovery. Studies have demonstrated improvements in memory, attention, and overall cognitive performance in patients treated with CEREMEXIN, significantly impacting their quality of life.

The medication’s mechanism of action, centered on cell membrane repair and neuroprotection, is a key advantage. By directly addressing the underlying cellular damage that contributes to neurological deficits, CEREMEXIN provides a targeted therapeutic approach. This targeted approach, focusing on cellular repair, sets it apart from some other treatments that may address symptoms without directly addressing the root cause of the problem.

Another significant advantage is CEREMEXIN’s generally good safety profile. While side effects are possible, the majority are mild and transient. This favorable safety profile makes CEREMEXIN a suitable option for a broader range of patients, including those who may not tolerate other treatments with more severe side effect profiles. The relatively low incidence of severe side effects enhances patient compliance and reduces the risk of treatment discontinuation due to adverse reactions.

Finally, the availability of CEREMEXIN via both intravenous and intramuscular routes of administration provides flexibility in treatment delivery. This flexibility allows healthcare professionals to tailor the administration method to the individual patient’s needs and circumstances. The choice between IV and IM injection allows for optimization of treatment based on factors like patient mobility and the severity of their condition. This versatility is a valuable asset in clinical practice.

Cons

While CEREMEXIN offers substantial therapeutic benefits, it’s essential to acknowledge potential drawbacks. One notable aspect is the need for parenteral administration; CEREMEXIN must be injected intravenously or intramuscularly, ruling out oral administration. This requirement necessitates medical supervision and may pose challenges for patients who are unable or unwilling to receive injections.

The occurrence of side effects, although generally mild, represents another consideration. While most side effects are transient and well-tolerated, the potential for gastrointestinal upset, headaches, and other less common adverse events should be acknowledged. These side effects, while usually manageable, can impact patient comfort and adherence to the treatment regimen. Careful monitoring and potential dosage adjustments are needed to minimize discomfort.

Furthermore, the cost of CEREMEXIN may be a factor for some patients. The expense associated with the medication, coupled with the need for medical supervision and administration, can present financial barriers to access. This cost consideration underscores the importance of considering the overall cost-effectiveness of CEREMEXIN within the context of its therapeutic benefits and potential long-term health outcomes.

Finally, the individualized nature of dosage and treatment duration necessitates frequent monitoring by healthcare professionals. This requirement adds to the overall complexity and resource intensity of CEREMEXIN therapy. The need for close medical supervision may not be feasible for all patients, particularly those in remote areas or with limited access to healthcare services. Careful consideration of these factors is crucial for informed decision-making regarding treatment.

Precautions and Contraindications

Before initiating CEREMEXIN therapy, a thorough assessment of the patient’s medical history is crucial. This includes a review of existing conditions, allergies, and current medications to identify any potential drug interactions or contraindications. The physician should carefully weigh the potential benefits of CEREMEXIN against any potential risks based on the patient’s individual circumstances. Open communication between the patient and physician is vital throughout the process.

While CEREMEXIN is generally well-tolerated, caution is warranted in patients with a history of hypersensitivity to citicoline or any of its components. Allergic reactions, ranging from mild skin rashes to severe anaphylaxis, are possible, although rare. A careful assessment of allergy history and close monitoring during initial administration are essential to mitigate potential allergic reactions. Appropriate emergency measures should be readily available in case of a severe allergic response.

Pregnancy and breastfeeding represent important considerations. The safety of CEREMEXIN during pregnancy and lactation has not been definitively established, necessitating a careful risk-benefit assessment. In pregnant or breastfeeding women, the physician should carefully weigh the potential risks to the mother and fetus or infant against the potential benefits of CEREMEXIN therapy. Alternative treatments may be considered if the risks outweigh the benefits.

Patients with severe renal or hepatic impairment may require dosage adjustments or close monitoring. The kidneys and liver play essential roles in drug metabolism and excretion. Impaired function in either organ can affect the pharmacokinetics of CEREMEXIN, potentially leading to accumulation of the drug and increased risk of adverse effects. Dosage adjustments, based on individual renal and hepatic function, are often necessary to ensure patient safety and efficacy. Regular monitoring of organ function is crucial during treatment.

  • Ceremexin™ Solution For Iv And Im Injection 250Mg/Ml (4Ml), Ampoules 5Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Ceremexin™ Solution For Iv And Im Injection 250Mg/Ml (4Ml), Ampoules 5Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Ceremexin™ Solution For Iv And Im Injection 250Mg/Ml (4Ml), Ampoules 5Pcs Buy Online 6
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “CEREMEXIN™ solution for IV and IM injection 250mg/ml (4ml), ampoules 5pcs”

Your email address will not be published. Required fields are marked

Similar products

GOPANTAM™ tablets 250mg, 50pcs

$18.00
Add to cart

HOPANTENIC ACID tablets 250mg, 50pcs

$28.00
Add to cart

GLYCINE RENEVAL™ buccal and sublingual tablets 100mg, 120pcs

$9.00
Add to cart

GLYCINE RENEVAL™ buccal and sublingual tablets 100mg, 60pcs

$7.00
Add to cart

GLYCINE sublingual tablets 100mg, 100pcs

$7.00
Add to cart

GLYCINE sublingual tablets 100mg, 50pcs

$6.00
Add to cart

GLIATILIN™ capsules 400mg, 56pcs

$159.00
Add to cart

GLEACER™ solution for IV/IM injection 250mg/ml (4ml), 5 ampoules

$14.00
Add to cart

GINKGO BILOBA tablets 120mg, 30pcs

$39.00
Add to cart

GINKOUM™ capsules 120mg, 30pcs

$66.00
Add to cart

GINKOUM™ capsules 40mg, 30pcs

$35.00
Add to cart

VINPOTROPIL™ tablets 10mg+800mg, 60pcs

$28.00
Add to cart

VINPOCETINE concentrate for infusion solution 5mg/ml (2ml), 10pcs

$13.00
Add to cart

VINPOCETINE tablets 5mg, 50pcs

$10.00
Add to cart

VINPOTROPIL™ capsules 5mg+400mg, 30pcs

$19.00
Add to cart

VINPOTROPIL™ capsules 5mg+400mg, 60pcs

$21.00
Add to cart

BRAINMAX™ solution for IV/IM injection 100mg/ml+100mg/ml (2.5ml), 10pcs

$159.00
Add to cart

BRAINMAX™ solution for IV/IM injection 100mg/ml+100mg/ml (5ml), 10pcs

$281.00
Add to cart

BILOBIL™ INTENS 120, 120mg capsules, 20pcs

$47.00
Add to cart

BILOBIL™ INTENS 120, 120mg capsules, 60pcs

$98.00
Add to cart

BILOBIL™ capsules 40mg, 60pcs

$60.00
Add to cart

ARMADIN™ 50 solution for IV/IM injection 50mg/ml (2ml), 10 ampoules

$28.00
Add to cart

AMINALON™ tablets 250mg, 100pcs

$20.00
Add to cart

AMINALON™ tablets 250mg, 100pcs

$18.00
Add to cart
Select your currency